Melanoma and Cutaneous Malignancy Tumor Board 2023-2024

---

RSSAAPACMECNEMOCSafetyPSRM - Patient Safety/Risk ManagementState Required CME

Occurs weekly every Wednesday starting on 1/4/2023 at 12:00 PM
Wednesday, January 4, 2023, 12:00 PM - 1:00 PM, PCAM South Tower Room 10-124, Philadelphia, PA

Melanoma and Cutaneous Malignancy Tumor Board is designed to give healthcare professionals the opportunity to collaborate on the care of patients who have been diagnosed with melanoma, skin cancer, or other skin malignancy/risk factors. Providers submit their most complex cases in order to seek insight on the best patient care via the collaboration of clinicians such as surgeons, oncologists, radiologists, pathologists, physician assistants, nurse practitioners, and registered nurses.

1. Discuss a multidisciplinary approach to care for patients with melanoma and other malignant skin diseases
2. Discuss how to provide a plan for accurate diagnosis, complete staging, and proper treatment for patients.
3. Describe how to treat and manage patients with melanoma and other cutaneous malignancies using both proven standardized methods and consider current investigative clinical trials.

In support of improving patient care, Penn Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.  

Designation of Credit
Physicians: Penn Medicine designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AMA PRA Category 1 Credits™ (1.00 hours), Non-Physician Attendance / Participation (1.00 hours), NCPD Hours (ANCC) (1.00 hours), ABIM MOC Part 2 (1.00 hours), Patient Safety/Risk Management PSRM (1.00 hours), ABPath MOC Part 2 (1.00 hours), American Academy of Physician Assistants (1.00 hours), ABS MOC Part 2 (1.00 hours)

Mitigation of Relevant Financial Relationships

Penn Medicine adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

No faculty are available for this activity at this time.

Date	Empty Column	Title
		No activities are currently published for this month.
No upcoming dates have been setup.